InsiderTrades.com logo
Cash Holders STILL Aren't Taking Steps to Prepare
From Investor Place Media   |   Ad
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
Click Here to Learn More

TBPH Insider Trading

Insider Ownership Percentage: 4.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $795,694.81

Theravance Biopharma Insider Trading History Chart

This chart shows the insider buying and selling history at Theravance Biopharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Theravance Biopharma Share Price & Price History

Current Price: $10.65
Price Change: ▼ Price Decrease of -0.05 (-0.47%)
As of 02/3/2023 01:00 AM ET

This chart shows the closing price history over time for TBPH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel

Theravance Biopharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/14/2022Rick E WinninghamCEOSell50,000$11.19$559,500.001,350,797View SEC Filing Icon  
12/1/2022Richard A GrahamSVPSell2,084$10.73$22,361.32313,520View SEC Filing Icon  
8/16/2022Richard A GrahamSVPSell4,906$9.71$47,637.26364,745View SEC Filing Icon  
8/9/2022Richard A GrahamSVPSell15,086$8.79$132,605.94369,651View SEC Filing Icon  
5/23/2022Rhonda FarnumSVPSell1,081$8.93$9,653.33329,990View SEC Filing Icon  
2/28/2022Rhonda FarnumSVPSell2,356$10.16$23,936.96View SEC Filing Icon  
3/9/2021Philip D WorboysSVPSell8,829$20.00$176,580.00343,679View SEC Filing Icon  
12/14/2020Richard A GrahamSVPSell7,500$19.47$146,025.00123,749View SEC Filing Icon  
12/3/2020Philip D WorboysSVPSell4,246$18.00$76,428.00319,395View SEC Filing Icon  
8/21/2020Brett K HaumannInsiderSell25,000$18.29$457,250.00307,810View SEC Filing Icon  
8/20/2020Philip D WorboysSVPSell17,103$18.00$307,854.00333,252View SEC Filing Icon  
See Full Table
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel

SEC Filings (Institutional Ownership Changes) for Theravance Biopharma (NASDAQ:TBPH)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TBPH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Theravance Biopharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/2/2023SG Americas Securities LLC15,407$0.17M0.0%-43.5%0.023%Search for SEC Filing on Google Icon
2/2/2023Gladius Capital Management LP3,553$40K0.0%N/A0.005%Search for SEC Filing on Google Icon
1/26/2023Strs Ohio16,300$0.18M0.0%N/A0.024%Search for SEC Filing on Google Icon
1/23/2023Allspring Global Investments Holdings LLC15,351$0.17M0.0%-25.6%0.023%Search for SEC Filing on Google Icon
1/17/2023Palliser Capital UK Ltd97,100$1.09M2.6%N/A0.144%Search for SEC Filing on Google Icon
12/8/2022Bank of New York Mellon Corp205,470$2.08M0.0%+12.9%0.305%Search for SEC Filing on Google Icon
12/6/2022Weiss Asset Management LP7,457,060$75.62M1.9%+19.6%11.069%Search for SEC Filing on Google Icon
12/5/2022Weiss Asset Management LP7,457,060$75.62M1.6%+19.6%11.069%Search for SEC Filing on Google Icon
11/16/2022BNP Paribas Arbitrage SNC15,957$0.16M0.0%-85.3%0.024%Search for SEC Filing on Google Icon
11/15/2022State Street Corp1,484,759$15.06M0.0%-0.7%2.204%Search for SEC Filing on Google Icon
11/15/2022Jacobs Levy Equity Management Inc.827,906$8.40M0.1%-3.7%1.229%Search for SEC Filing on Google Icon
11/15/2022Algert Global LLC30,700$0.31M0.0%-56.1%0.046%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Advisers LP696,600$7.06M0.0%N/A1.034%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Investments LP652,870$6.62M0.0%N/A0.969%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.6,006,133$60.90M0.0%-8.2%8.916%Search for SEC Filing on Google Icon
11/15/2022Price T Rowe Associates Inc. MD80,577$0.82M0.0%+13.0%0.120%Search for SEC Filing on Google Icon
11/15/2022Putnam Investments LLC102,156$1.04M0.0%-1.8%0.152%Search for SEC Filing on Google Icon
11/15/2022Park West Asset Management LLC1,919,354$19.46M1.4%-39.5%2.849%Search for SEC Filing on Google Icon
11/15/2022Bank of New York Mellon Corp205,470$2.08M0.0%+12.9%0.305%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.5,107,527$51.79M0.0%+1.7%7.581%Search for SEC Filing on Google Icon
11/15/2022Brandywine Global Investment Management LLC93,249$0.95M0.0%-3.7%0.138%Search for SEC Filing on Google Icon
11/14/2022Royal Bank of Canada6,610$67K0.0%+1,330.7%0.010%Search for SEC Filing on Google Icon
11/14/2022Baupost Group LLC MA13,419,226$136.07M2.3%-67.7%19.920%Search for SEC Filing on Google Icon
11/14/2022Cubist Systematic Strategies LLC113,867$1.16M0.0%+25.7%0.169%Search for SEC Filing on Google Icon
11/14/2022PDT Partners LLC81,658$0.83M0.1%-47.7%0.121%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC152,177$1.54M0.0%N/A0.226%Search for SEC Filing on Google Icon
11/14/2022Boothbay Fund Management LLC35,477$0.36M0.0%N/A0.053%Search for SEC Filing on Google Icon
11/14/2022Centiva Capital LP41,300$0.42M0.0%N/A0.061%Search for SEC Filing on Google Icon
11/14/2022Nuveen Asset Management LLC176,173$1.79M0.0%-26.6%0.262%Search for SEC Filing on Google Icon
11/14/2022Rubric Capital Management LP356,100$3.61M0.2%N/A0.529%Search for SEC Filing on Google Icon
11/14/2022Pictet Asset Management SA370,379$3.76M0.0%+41.7%0.550%Search for SEC Filing on Google Icon
11/10/2022Tower Research Capital LLC TRC 9,877$100K0.0%+292.4%0.015%Search for SEC Filing on Google Icon
11/10/2022Bank of Montreal Can205,680$2.10M0.0%-5.4%0.305%Search for SEC Filing on Google Icon
11/7/2022Quantbot Technologies LP13,900$0.14M0.0%+101.3%0.021%Search for SEC Filing on Google Icon
11/7/2022Jump Financial LLC58,000$0.59M0.0%N/A0.086%Search for SEC Filing on Google Icon
11/4/2022Russell Investments Group Ltd.58,970$0.60M0.0%-95.7%0.088%Search for SEC Filing on Google Icon
11/3/2022Barclays PLC11,198$0.11M0.0%-46.6%0.017%Search for SEC Filing on Google Icon
11/2/2022Cannon Global Investment Management LLC65,000$0.66M1.1%N/A0.096%Search for SEC Filing on Google Icon
11/2/2022Victory Capital Management Inc.110,350$1.12M0.0%+73.4%0.164%Search for SEC Filing on Google Icon
10/31/2022SG Americas Securities LLC27,265$0.28M0.0%+54.1%0.040%Search for SEC Filing on Google Icon
10/26/2022Allspring Global Investments Holdings LLC20,633$0.21M0.0%+14.1%0.031%Search for SEC Filing on Google Icon
8/22/2022Legal & General Group Plc58,904$0.53M0.0%+2.6%0.077%Search for SEC Filing on Google Icon
8/19/2022Walleye Capital LLC82,758$0.75M0.0%+118.9%0.108%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.583,029$5.28M0.0%-40.3%0.763%Search for SEC Filing on Google Icon
8/16/2022Woodline Partners LP2,243,473$20.33M0.3%+69.1%2.935%Search for SEC Filing on Google Icon
8/16/2022Price T Rowe Associates Inc. MD71,313$0.65M0.0%+57.0%0.093%Search for SEC Filing on Google Icon
8/16/2022Park West Asset Management LLC3,173,254$28.75M1.6%+833.3%4.152%Search for SEC Filing on Google Icon
8/15/2022State Street Corp1,495,046$13.55M0.0%-3.0%1.956%Search for SEC Filing on Google Icon
8/15/2022PDT Partners LLC156,131$1.42M0.1%-19.0%0.204%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC90,569$0.82M0.0%-41.4%0.119%Search for SEC Filing on Google Icon
8/15/2022Point72 Asset Management L.P.105,900$0.96M0.0%-83.9%0.139%Search for SEC Filing on Google Icon
8/15/2022UBS Asset Management Americas Inc.72,418$0.66M0.0%-3.1%0.095%Search for SEC Filing on Google Icon
8/13/2022Quantbot Technologies LP6,905$62K0.0%N/A0.009%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp595,234$5.39M0.0%+1.0%0.784%Search for SEC Filing on Google Icon
8/12/2022Virtus ETF Advisers LLC27,109$0.25M0.1%-25.4%0.036%Search for SEC Filing on Google Icon
8/12/2022Chescapmanager LLC1,160,503$10.51M2.5%-0.5%1.529%Search for SEC Filing on Google Icon
8/12/2022Credit Suisse AG71,238$0.65M0.0%+9.0%0.093%Search for SEC Filing on Google Icon
8/12/2022FMR LLC2,698,350$24.45M0.0%+0.1%3.530%Search for SEC Filing on Google Icon
8/12/2022BNP Paribas Arbitrage SA108,650$0.98M0.0%-12.5%0.143%Search for SEC Filing on Google Icon
8/12/2022Brandywine Global Investment Management LLC96,800$0.88M0.0%-12.9%0.128%Search for SEC Filing on Google Icon
8/12/2022Franklin Resources Inc.11,249$0.10M0.0%-30.8%0.015%Search for SEC Filing on Google Icon
8/12/2022Rhumbline Advisers74,880$0.68M0.0%+18.5%0.099%Search for SEC Filing on Google Icon
8/11/2022King Wealth45,000$0.41M0.1%-63.1%0.059%Search for SEC Filing on Google Icon
8/11/2022Bank of Montreal Can217,527$1.95M0.0%N/A0.287%Search for SEC Filing on Google Icon
8/11/2022JPMorgan Chase & Co.207,355$1.88M0.0%+19.7%0.273%Search for SEC Filing on Google Icon
8/10/2022Principal Financial Group Inc.17,674$0.16M0.0%+67.9%0.023%Search for SEC Filing on Google Icon
8/9/2022Pictet Asset Management SA261,427$2.37M0.0%+40.0%0.344%Search for SEC Filing on Google Icon
8/8/2022First Pacific Advisors LP176,539$1.60M0.0%+26.3%0.233%Search for SEC Filing on Google Icon
8/8/2022Walleye Capital LLC82,758$0.75M0.0%+118.9%0.109%Search for SEC Filing on Google Icon
8/8/2022Walleye Trading LLC14,475$0.13M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/1/2022Victory Capital Management Inc.63,650$0.58M0.0%N/A0.084%Search for SEC Filing on Google Icon
8/1/2022ProShare Advisors LLC13,162$0.12M0.0%-30.7%0.017%Search for SEC Filing on Google Icon
7/29/2022SG Americas Securities LLC17,698$0.16M0.0%N/A0.023%Search for SEC Filing on Google Icon
7/26/2022Mirae Asset Global Investments Co. Ltd.34,794$0.32M0.0%N/A0.046%Search for SEC Filing on Google Icon
7/25/2022Allspring Global Investments Holdings LLC18,086$0.16M0.0%+62.3%0.024%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE668,896$6.40M0.0%-67.3%0.881%Search for SEC Filing on Google Icon
5/27/2022Walleye Capital LLC37,800$0.36M0.0%N/A0.050%Search for SEC Filing on Google Icon
5/18/2022BNP Paribas Arbitrage SA124,234$1.19M0.0%+61.9%0.164%Search for SEC Filing on Google Icon
5/17/2022Walleye Capital LLC37,800$0.36M0.0%N/A0.050%Search for SEC Filing on Google Icon
5/17/2022Royal Bank of Canada13,032$0.12M0.0%-47.5%0.017%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System73,158$0.70M0.0%-7.5%0.096%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.976,373$9.34M0.0%+184.0%1.286%Search for SEC Filing on Google Icon
5/16/2022PDT Partners LLC192,701$1.84M0.2%+73.0%0.254%Search for SEC Filing on Google Icon
5/16/2022Woodline Partners LP1,326,653$12.68M0.2%+130.7%1.748%Search for SEC Filing on Google Icon
5/16/2022Wellington Management Group LLP148,387$1.42M0.0%-25.1%0.195%Search for SEC Filing on Google Icon
5/16/2022State Street Corp1,541,533$14.74M0.0%+13.3%2.031%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG3,549$34K0.0%+45.0%0.005%Search for SEC Filing on Google Icon
5/13/2022Chescapmanager LLC1,166,574$11.15M1.5%-7.5%1.537%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp589,053$5.63M0.0%-4.1%0.776%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.402,640$3.85M0.0%+3.1%0.530%Search for SEC Filing on Google Icon
5/13/2022American International Group Inc.29,790$0.29M0.0%-6.6%0.039%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.6,947,947$66.42M0.0%+10.3%9.154%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.4,929,140$47.12M0.0%-1.5%6.494%Search for SEC Filing on Google Icon
5/12/2022Panagora Asset Management Inc.270,691$2.59M0.0%+4.4%0.357%Search for SEC Filing on Google Icon
5/12/2022Acadian Asset Management LLC8,277$77K0.0%+51.6%0.011%Search for SEC Filing on Google Icon
5/12/2022King Wealth122,000$1.17M0.2%+838.5%0.161%Search for SEC Filing on Google Icon
5/12/2022Connor Clark & Lunn Investment Management Ltd.40,477$0.39M0.0%+22.5%0.053%Search for SEC Filing on Google Icon
5/11/2022First Pacific Advisors LP139,774$1.34M0.0%N/A0.184%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.173,292$1.66M0.0%-15.5%0.228%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP49,456$0.47M0.1%N/A0.065%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Theravance Biopharma logo
Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. Its research is focused in the areas of inflammation and immunology. In pursuit of its purpose, Theravance Biopharma applies insights and innovation at each stage of its business and utilizes its internal capabilities and those of partners around the world. The Company applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. These efforts leverage years of experience in developing lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI® (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Its pipeline of internally discovered programs is targeted to address significant patient needs. Theravance Biopharma has an economic interest in potential future payments from Glaxo Group Limited or one of its affiliates (GSK) pursuant to its agreements with Innoviva, Inc. relating to certain programs, including TRELEGY. For more information, please visit www.theravance.com.
Read More on Theravance Biopharma

Today's Range

Now: $10.65
Low: $10.62
High: $10.84

50 Day Range

MA: $10.93
Low: $10.40
High: $11.44

52 Week Range

Now: $10.65
Low: $7.53
High: $11.83

Volume

310,361 shs

Average Volume

423,876 shs

Market Capitalization

$717.49 million

P/E Ratio

0.95

Dividend Yield

N/A

Beta

0.51

Who are the company insiders with the largest holdings of Theravance Biopharma?

Theravance Biopharma's top insider shareholders include:
  1. Rick E Winningham (CEO)
  2. Richard A Graham (SVP)
  3. Philip D Worboys (SVP)
  4. Rhonda Farnum (SVP)
Learn More about top insider investors at Theravance Biopharma.

Who are the major institutional investors of Theravance Biopharma?

Theravance Biopharma's top institutional shareholders include:
  1. Palliser Capital UK Ltd — 0.14%
  2. Strs Ohio — 0.02%
  3. SG Americas Securities LLC — 0.02%
  4. Allspring Global Investments Holdings LLC — 0.02%
  5. Gladius Capital Management LP — 0.01%
  6. Simplex Trading LLC — 0.00%
Learn More about top institutional investors of Theravance Biopharma stock.

Which major investors are selling Theravance Biopharma stock?

During the last quarter, TBPH stock was sold by these institutional investors:
  1. Simplex Trading LLC
  2. SG Americas Securities LLC
  3. Allspring Global Investments Holdings LLC
Within the previous year, company insiders that have sold Theravance Biopharma company stock include:
  1. Rick E Winningham (CEO)
  2. Richard A Graham (SVP)
  3. Philip D Worboys (SVP)
Learn More investors selling Theravance Biopharma stock.

Which major investors are buying Theravance Biopharma stock?

During the previous quarter, TBPH stock was bought by institutional investors including:
  1. Palliser Capital UK Ltd
  2. Strs Ohio
  3. Gladius Capital Management LP
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel